Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Beitsch

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Annals of Surgical Oncology|October 23, 2016
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular SubtypingPat Whitworth, Peter Beitsch, Angela Mislowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancerThomas B Julian, Peter Blumencranz, Kenneth Deck, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2012
Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trialAtif J Khan, Frank A Vicini, Peter Beitsch, et al.
JAMA Surgery|May 11, 2022
Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled TrialE Shelley Hwang, Peter Beitsch, Peter Blumencranz, et al.
Annals of Surgical Oncology|December 31, 2015
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant ChemotherapyPaul Baron, Peter Beitsch, Danielle Boselli, et al.
Oncotargets and Therapy|May 10, 2011
Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysisWilliam C Dooley, James C Wurzer, Mohamed Megahy, et al.
American Journal of Surgery|September 19, 2006
Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumorsLorraine Tafra, Richard Fine, Pat Whitworth, et al.
Annals of Surgical Oncology|April 28, 2017
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Peter Beitsch, Pat Whitworth, Paul Baron, et al.
Annals of Surgical Oncology|July 29, 2015
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus ConferenceJeffrey Landercasper, Deanna Attai, Dunya Atisha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2006
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissuesSongdong Meng, Debu Tripathy, Sanjay Shete, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|October 23, 2016
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular SubtypingPat Whitworth, Peter Beitsch, Angela Mislowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancerThomas B Julian, Peter Blumencranz, Kenneth Deck, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2012
Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trialAtif J Khan, Frank A Vicini, Peter Beitsch, et al.
JAMA Surgery|May 11, 2022
Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled TrialE Shelley Hwang, Peter Beitsch, Peter Blumencranz, et al.
Annals of Surgical Oncology|December 31, 2015
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant ChemotherapyPaul Baron, Peter Beitsch, Danielle Boselli, et al.
Oncotargets and Therapy|May 10, 2011
Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysisWilliam C Dooley, James C Wurzer, Mohamed Megahy, et al.
American Journal of Surgery|September 19, 2006
Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumorsLorraine Tafra, Richard Fine, Pat Whitworth, et al.
Annals of Surgical Oncology|April 28, 2017
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Peter Beitsch, Pat Whitworth, Paul Baron, et al.
Annals of Surgical Oncology|July 29, 2015
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus ConferenceJeffrey Landercasper, Deanna Attai, Dunya Atisha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2006
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissuesSongdong Meng, Debu Tripathy, Sanjay Shete, et al.
Pageof 5